Zoetis Inc. $ZTS Shares Sold by Vanguard Personalized Indexing Management LLC

Vanguard Personalized Indexing Management LLC trimmed its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 19.2% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 56,011 shares of the company’s stock after selling 13,314 shares during the period. Vanguard Personalized Indexing Management LLC’s holdings in Zoetis were worth $8,203,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of ZTS. Halbert Hargrove Global Advisors LLC raised its position in shares of Zoetis by 496.6% during the 3rd quarter. Halbert Hargrove Global Advisors LLC now owns 173 shares of the company’s stock worth $25,000 after buying an additional 144 shares in the last quarter. REAP Financial Group LLC grew its holdings in Zoetis by 201.5% during the second quarter. REAP Financial Group LLC now owns 196 shares of the company’s stock worth $31,000 after acquiring an additional 131 shares during the period. NewSquare Capital LLC raised its position in Zoetis by 69.1% in the second quarter. NewSquare Capital LLC now owns 208 shares of the company’s stock worth $32,000 after acquiring an additional 85 shares in the last quarter. ORG Partners LLC lifted its holdings in Zoetis by 56.8% in the 2nd quarter. ORG Partners LLC now owns 232 shares of the company’s stock valued at $37,000 after acquiring an additional 84 shares during the last quarter. Finally, Financial Consulate Inc. bought a new position in shares of Zoetis during the 3rd quarter valued at about $39,000. Institutional investors own 92.80% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms recently commented on ZTS. KeyCorp started coverage on shares of Zoetis in a report on Thursday, November 20th. They issued a “sector weight” rating on the stock. Stifel Nicolaus dropped their price target on Zoetis from $140.00 to $130.00 and set a “hold” rating on the stock in a report on Tuesday, November 18th. The Goldman Sachs Group raised Zoetis to a “buy” rating in a research note on Monday, December 15th. BTIG Research reaffirmed a “buy” rating and set a $160.00 target price on shares of Zoetis in a research report on Wednesday, December 3rd. Finally, Piper Sandler reiterated a “neutral” rating and issued a $135.00 price target (down previously from $190.00) on shares of Zoetis in a research report on Thursday. Five research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. According to data from MarketBeat.com, Zoetis currently has a consensus rating of “Hold” and a consensus target price of $152.91.

Zoetis Stock Performance

ZTS stock opened at $123.89 on Tuesday. The stock has a market cap of $54.60 billion, a P/E ratio of 20.86, a P/E/G ratio of 2.15 and a beta of 0.97. Zoetis Inc. has a 52 week low of $115.25 and a 52 week high of $177.40. The firm has a 50 day simple moving average of $123.68 and a 200 day simple moving average of $137.91. The company has a debt-to-equity ratio of 1.31, a quick ratio of 2.28 and a current ratio of 3.64.

Zoetis (NYSE:ZTS) last announced its quarterly earnings results on Tuesday, November 4th. The company reported $1.70 earnings per share for the quarter, topping analysts’ consensus estimates of $1.62 by $0.08. Zoetis had a return on equity of 57.19% and a net margin of 28.21%.The company had revenue of $2.40 billion during the quarter, compared to analysts’ expectations of $2.42 billion. During the same quarter in the previous year, the firm earned $1.58 earnings per share. The business’s quarterly revenue was up .5% compared to the same quarter last year. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Research analysts anticipate that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 3rd. Investors of record on Tuesday, January 20th will be paid a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a yield of 1.7%. The ex-dividend date is Tuesday, January 20th. This is a positive change from Zoetis’s previous quarterly dividend of $0.50. Zoetis’s dividend payout ratio is currently 35.69%.

About Zoetis

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.